Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00005918

Public ClinicalTrials.gov record NCT00005918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:03 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Safety and Antiviral Efficacy of Stavudine Extended Release Formulation as Compared to Stavudine Immediate Release Formulation, Each as Part of Potent Antiretroviral Combination Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and effectiveness of 2 forms of stavudine (d4T). One form is taken once a day (extended release) and the other form is taken twice a day (immediate release).

Study identification

NCT ID
NCT00005918
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
730 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2000 (Type not available)
Primary completion
Apr 2002 (Actual)
Completion
Apr 2002 (Actual)
Last update posted
May 4, 2011

2000 – 2002

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
AIDS Healthcare Foundation Los Angeles California 90027 —
Whitman Walker Clinic Washington D.C. District of Columbia 20009 —
IDC Research Initiative Altamonte Springs Florida 32701 —
Med Alternatives Fort Lauderdale Florida 33308 —
Hillsborough County Health Dept Tampa Florida 33602 —
The CORE Ctr Chicago Illinois 60612 —
Univ of Kansas School of Medicine Wichita Kansas 672143124 —
Univ of Louisville Louisville Kentucky 40292 —
CRI of New England Brookline Massachusetts 02445 —
CRI - Springfield Springfield Massachusetts 01107 —
No Nevada HOPES Reno Nevada 89520 —
Saint Luke's - Roosevelt Hosp Ctr New York New York 10019 —
Univ Hospital Oklahoma City Oklahoma 73104 —
Aesculapisu Medical Health Group Dallas Texas 75204 —
Univ of Texas Southwestern Med Ctr Dallas Texas 75390 —
Univ of Texas Med Branch Galveston Texas 775550835 —
Plaza Med Ctr Houston Texas 77004 —
Hampton Roads Med Specialists Hampton Virginia 23666 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00005918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2011 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00005918 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →